Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.4954
+0.0174 (3.64%)
Aug 18, 2026, 1:34 PM EDT - Market open
Pasithea Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 45.66 | 55.16 | 6.92 | 16.33 | 33.09 | 52.97 |
Cash & Short-Term Investments | 45.66 | 55.16 | 6.92 | 16.33 | 33.09 | 52.97 |
Cash Growth | 532.72% | 696.78% | -57.61% | -50.64% | -37.53% | 21638.85% |
Other Receivables | - | - | - | 0.04 | - | - |
Receivables | - | - | - | 0.04 | - | - |
Prepaid Expenses | 2.46 | 0.81 | 0.3 | 0.22 | 0.56 | 0.33 |
Restricted Cash | 0.1 | 0.1 | - | - | - | - |
Other Current Assets | 0.02 | 0.39 | 0.14 | 0.1 | 0.43 | - |
Total Current Assets | 48.24 | 56.46 | 7.37 | 16.69 | 34.08 | 53.3 |
Property, Plant & Equipment | - | - | 0.12 | 0.22 | 0.63 | 0.02 |
Goodwill | - | - | 1.26 | 1.26 | 1.26 | - |
Other Intangible Assets | 3.47 | 3.78 | 7.31 | 7.94 | 8.57 | - |
Other Long-Term Assets | - | - | - | - | 0.64 | - |
Total Assets | 51.71 | 60.24 | 16.06 | 26.12 | 45.18 | 53.32 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.84 | 1.13 | 1.12 | 2.55 | 1.48 | 0.45 |
Current Portion of Leases | - | - | - | 0.08 | 0.16 | - |
Other Current Liabilities | - | 3.84 | - | - | 0.24 | - |
Total Current Liabilities | 1.84 | 4.97 | 1.12 | 2.63 | 1.88 | 0.45 |
Long-Term Leases | - | - | - | - | 0.34 | - |
Other Long-Term Liabilities | 0.03 | 0.05 | 0.16 | 0.08 | 0.46 | 1.45 |
Total Liabilities | 1.87 | 5.02 | 1.28 | 2.72 | 2.68 | 1.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.02 |
Additional Paid-In Capital | 127.98 | 125.21 | 64.37 | 58.72 | 61.86 | 53.63 |
Retained Earnings | -78.15 | -70.01 | -49.58 | -35.32 | -19.36 | -2.21 |
Comprehensive Income & Other | 0.01 | 0.02 | -0.01 | -0 | -0 | -0.01 |
Shareholders' Equity | 49.84 | 55.22 | 14.78 | 23.4 | 42.5 | 51.42 |
Total Liabilities & Equity | 51.71 | 60.24 | 16.06 | 26.12 | 45.18 | 53.32 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | 0.08 | 0.5 | - |
Net Cash (Debt) | 45.66 | 55.16 | 6.92 | 16.25 | 32.58 | 52.97 |
Net Cash Growth | 532.72% | 696.78% | -57.40% | -50.13% | -38.48% | 21638.85% |
Net Cash Per Share | 2.38 | 7.85 | 6.32 | 13.25 | 25.81 | 101.81 |
Filing Date Shares Outstanding | 33.41 | 24.94 | 2.71 | 1.04 | 1.31 | 1.14 |
Total Common Shares Outstanding | 33.41 | 23.09 | 1.39 | 1.04 | 1.3 | 1.15 |
Working Capital | 46.41 | 51.49 | 6.25 | 14.06 | 32.2 | 52.85 |
Book Value Per Share | 1.49 | 2.39 | 10.60 | 22.46 | 32.64 | 44.70 |
Tangible Book Value | 46.37 | 51.44 | 6.21 | 14.19 | 32.66 | 51.42 |
Tangible Book Value Per Share | 1.39 | 2.23 | 4.45 | 13.63 | 25.08 | 44.70 |
Machinery | - | - | 0.16 | 0.16 | 0.13 | 0.02 |
Leasehold Improvements | - | - | 0 | 0 | 0 | - |